Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.46 |
| ▸ | MAX | P61244 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | AR | P10275 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22660910 | 0.89 | AKR1C3 (0.52) | MAPTALDH1A1LMNAMEN1NPC1 | |
| SCHEMBL29682151 | 0.88 | GAA (0.62) | MAPTGAASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL11691516 | 0.88 | GAA (0.62) | MAPTGAASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL22660921 | 0.87 | AKR1C3 (0.59) | MAPTALDH1A1LMNAPOLBKMT2A | |
| SCHEMBL3537490 | 0.87 | MAPT (0.62) | MAPTGAALMNAPOLBAKR1C3 | |
| SCHEMBL13318974 | 0.87 | POLB (0.59) | MAPTGAASMN1; SMN2ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL3729179 | 0.85 | MAPT (0.60) | MAPTGAAPOLBAKR1C3AKR1C2 | |
| SCHEMBL1935497 | 0.85 | MAPK1 (0.60) | MAPTGAASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL16960732 | 0.85 | MAPT (0.55) | MAPTGAASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL221362 | 0.84 | AR (0.61) | MAPTGAASMN1; SMN2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114945636-B | Azo compound or salt thereof, polarizing film, polarizing plate, and display device | 日本化药株式会社 | 2024-07-12 | — | — | CN | disclosed |
| CN-116261924-A | Polarizing element, polarizing plate, and display device provided with same | 日本化药株式会社 | 2023-06-13 | — | — | CN | disclosed |
| CN-114945636-A | Azo compound or salt thereof, and dye-based polarizing film, dye-based polarizing plate, and display device containing the same | 日本化药株式会社 | 2022-08-26 | — | — | CN | disclosed |
| CN-111433290-B | Azo compound or salt thereof, and polarizing element, polarizing plate and display device each comprising the same | 日本化药株式会社 | 2022-06-14 | — | — | CN | disclosed |
| WO-2022071201-A1 | POLARIZING ELEMENT, POLARIZING PLATE, AND DISPLAY DEVICE PROVIDED WITH SAME | 日本化薬株式会社 | 2022-04-07 | — | — | WO | disclosed |
| CN-113795554-A | Achromatic polarizing element, and achromatic polarizing plate and display device using same | 日本化药株式会社 | 2021-12-14 | — | — | CN | disclosed |
| WO-2021153374-A1 | AZO COMPOUND OR SALT THEREOF, AND DYE-BASED POLARIZING FILM, DYE-BASED POLARIZING PLATE AND DISPLAY DEVICE EACH CONTAINING SAME | 日本化薬株式会社 | 2021-08-05 | — | — | WO | disclosed |
| WO-2020230647-A1 | ACHROMATIC POLARIZER, ACHROMATIC POLARIZING PLATE USING SAME, AND DISPLAY DEVICE | 日本化薬株式会社 | 2020-11-19 | — | — | WO | disclosed |
| CN-111433290-A | Azo compound or salt thereof, and polarizing element, polarizing plate and display device each containing the same | 日本化药株式会社 | 2020-07-17 | — | — | CN | disclosed |
| US-20100158996-A1 | ESTER COMPOUND AND MEDICAL USE THEREOF | JAPAN TOBACCO INC. | 2010-06-24 | — | — | US | disclosed |
| US-7625948-B2 | Ester compound and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2009-12-01 | — | — | US | disclosed |
| US-7625948-B2 | Ester compound and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2009-12-01 | — | — | US | disclosed |
| US-7432392-B2 | Ester derivatives and medical use thereof | JAPAN TOBACCO INC. (JP) | 2008-10-07 | — | — | US | disclosed |
| US-7432392-B2 | Ester derivatives and medical use thereof | JAPAN TOBACCO INC. (JP) | 2008-10-07 | — | — | US | disclosed |
| US-7432392-B2 | Ester derivatives and medical use thereof | JAPAN TOBACCO INC. (JP) | 2008-10-07 | — | — | US | disclosed |
| US-20060205726-A1 | Ester derivatives and medical use thereof | JAPAN TOBACCO INC. (JP) | 2006-09-14 | — | — | US | disclosed |
| EP-1669345-A1 | ESTER DERIVATIVE AND MEDICINAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2006-06-14 | — | — | EP | disclosed |
| US-20050075367-A1 | Ester compound and medicinal use thereof | JAPAN TOBACCO INC. (JP) | 2005-04-07 | — | — | US | disclosed |
| EP-1479666-A1 | ESTER COMPOUND AND MEDICINAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-4052444-A | DIAZO COUPLERS FOR MONOAZO DYES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205726-A1 | Ester derivatives and medical use thereof | MTTP, LIPC, CETP | MAPT 3711/4885GAA 237/4885SMN1; SMN2 4460/4885 |
| US-20050075367-A1 | Ester compound and medicinal use thereof | LIPC, CES1, MTTP | MAPT 4387/4885GAA 2055/4885SMN1; SMN2 4775/4885 |
| US-20100158996-A1 | ESTER COMPOUND AND MEDICAL USE THEREOF | LIPC, CES1, MTTP | MAPT 4163/4885GAA 1962/4885SMN1; SMN2 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.